Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Engineered Lactococcus lactis for oral delivery of BoIFN-α/β2: A biotherapeutic strategy for mucosal antiviral defense.

Created on 15 Nov 2026

Authors

Mingze Chen, Hongzhe Zhao, Qiying Han, Shilong You, Yingying Ma, Changcheng Zhu, Chenyu Zheng, Fei Teng, Wei Wu, Wenyue Zhao, Xiaoman Li, Yanping Jiang, Jiaxuan Li, Wen Cui, Xinyuan Qiao

Published in

Veterinary microbiology. Volume 323. Pages 111287. Nov 11, 2026. Epub Nov 11, 2026.

Abstract

Interferons (IFNs) are key broad-spectrum antiviral cytokines and represent an important complement to conventional vaccination. However, the application of bovine interferons (BoIFNs) is limited by poor in vivo stability, short biological half-life, and inconvenient delivery. Whether fusion of different BoIFN subtypes can enhance antiviral activity also remains unclear. In this study, BoIFN-β1, BoIFN-β2, BoIFN-β3, and BoIFN-γ were expressed in Escherichia coli, and four fusion proteins (BoIFN-α-β2, BoIFN-α-γ, BoIFN-β2-γ, and BoIFN-α-β2-γ) were constructed. All fusion proteins exhibited lower antiviral activity than BoIFN-α and BoIFN-β2 monomers, indicating that direct fusion did not confer synergistic enhancement. Subsequently, a food-grade pNZ8149/NZ3900 system was used for antibiotic resistance marker-free secretory expression of BoIFN-α and BoIFN-β2 in Lactococcus lactis (L. lactis). Recombinant culture supernatants showed no apparent cytotoxicity toward Madin-Darby bovine kidney (MDBK) cells, inhibited bovine enterovirus (BEV) and vesicular stomatitis virus (VSV) replication, and induced MX1, OAS1, ISG15, and IFITM1 expression. In BALB/c mice, oral administration of recombinant L. lactis increased splenic OAS1 and ISG15 expression and alleviated VSV-induced weight loss, tissue viral loads, and histopathological lesions, with greater prophylactic than therapeutic efficacy. Collectively, this study defines the limitations of BoIFN fusion strategies for antiviral enhancement and establishes a food-grade L. lactis-based oral BoIFN delivery system, provides a preliminary candidate strategy for the prevention and control of bovine viral diseases, which warrants further validation in cattle.

PMID:
43033737
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement